All Lobbying articles
-
BusinessOut of the suburbs: the rise of urban labs
Could empty office blocks and shopping centres provide much-needed space for growing companies?
-
BusinessThe hole in the UK chemical industry
Norman Keane thinks ICI’s breakup has left a gap in scale-up knowhow and skills, as well as a lack of facilites
-
BusinessUS reviews chemical incident prevention planning rules
Risk Management Program has been extended and rolled back under successive governments
-
BusinessNew Trump tariffs worry North American chemical industries
High duties on imports from Canada, Mexico and China raise problems for international supply chains
-
NewsUK government must prioritise science education in upcoming spending review, says RSC
Royal Society of Chemistry also calls for investment in sustainable chemicals sector
-
BusinessDow to cut 1500 jobs as global chemicals industry reshapes
US firm joins other industry heavyweights in shedding jobs to cut costs
-
NewsAfter years of negotiations, a global agreement to tackle plastic pollution is within sight
The UN’s plastics treaty negotiations have faced many hurdles, but delegates are getting closer to a final agreement
-
BusinessRSC calls on government to address lab space shortage
Decades-long shortfall in suitable facilities has held back growth and innovation
-
BusinessUK’s Grangemouth refinery will close in 2025
Petroineos will convert site into a fuel import terminal with loss of 400 jobs
-
NewsNobel laureates urge European Commission president to fund science and appoint a research champion
Letter calls on Ursula von der Leyen to nominate ‘a strong supporter of research’ as the next commissioner for research and innovation
-
BusinessOil and gas industry emissions are not on track to hit climate goals
Several big firms have rolled back their targets, saying governments need to set pace with policy
-
BusinessUS government moves to block Chinese biotechs’ operations
WuXi Apptec and others accused of national security risk, as trade groups back legislation limiting their activities
-
BusinessUS industry leaders repeat calls to reinstate security programme
Six month gap in vetting people with access to high-risk chemicals means potential threats may have been missed
-
BusinessEU renewal of glyphosate approval formally challenged
Environmental coalition says independent data was not considered in decision
-
BusinessChemicals roundup 2023
Chemical companies entered cost-cutting mode in a year dominated by overcapacity and slow demand
-
BusinessUK diverges from EU rules with cosmetics animal testing ban
UK will no longer allow Reach-required animal tests intended to prove worker safety
-
BusinessChemicals industry roundup 2022
Russia’s invation of Ukraine mounted further pressure onto already strained supply chains
-
BusinessPharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
-
BusinessEuropean chemicals industry struggling to compete as costs surge
BASF plans major cost cuts as energy crisis saps profits
-
OpinionWhen regulatory cooperation goes too far, we all lose
Were FDA staff unduly influenced by Biogen in approving Alzheimer’s antibody?